Lei Meng

**Title: Innovating Diagnostics: The Contributions of Lei Meng**

Introduction

Lei Meng, an accomplished inventor based in Xi'an, China, has made significant strides in the field of genetic diagnostics. With a patent to his name, he is recognized for his innovative approach to detecting genetic alleles using fluorescent PCR methods.

Latest Patents

Among Lei Meng's contributions is his notable patent titled "Fluorescent PCR method for detecting HLA-B*15:02 allele and specific primer probe combination thereof." This advanced methodology involves the design of a set of primers and probes based on the HLA-B*15:02 specific SNP gene locus through the utilization of TaqMan probe technology. The invention combines these specific probes with others corresponding to an internal reference gene, β-Actin, allowing for the detection of whether a DNA sample contains the HLA-B*15:02 gene and determining the homozygosity or heterozygosity of the sample. This innovative technique offers improved specificity, high throughput, low operational costs, and ease of use, making it a noteworthy advancement over previous methods.

Career Highlights

Lei Meng is affiliated with Shaan Xi Lifegen Co., Ltd., where he has cultivated a career focused on enhancing genetic detection technologies. His pioneering work in fluorescent PCR has established him as a key figure in the realm of genetic research and diagnostics.

Collaborations

Meng has collaborated with distinguished colleagues, including Penggao Dai and Zihua Zhong, to further his research and development initiatives. Their collective efforts have not only amplified the impact of Meng's innovations but have also promoted collaborative advancements in the field of genetic diagnostics.

Conclusion

In summary, Lei Meng's innovative methods in detecting the HLA-B*15:02 allele through fluorescent PCR represent a significant leap forward in genetic diagnostics. His contributions underscore the crucial role of inventors in advancing medical technology and improving patient outcomes. As he continues to work with talented colleagues at Shaan Xi Lifegen Co., Ltd., the future of genetic research looks promising.